Children’s of Mississippi Hospital - Blair E. Batson Tower
Return to Locations Search
Address:
2500 N. State St.
Jackson, MS 39216
Contact Us:
(601) 815-8010
Parking:
Garage B or C
Parking Information and Interactive Campus Map
Directions:
To reach a specific room, call (601) 815 + room number.
Our Care Specialties at this location:
- Child and Adolescent Psychiatry
- Child Development
- Children's Audiology
- Children's Craniofacial and Trauma Surgery
- Children's Craniofacial and Trauma Surgery
- Children's Critical Care
- Children's Dentistry
- Children's General Surgery
- Children's Hospital Medicine
- Children's Neurosurgery
- Children's Plastic and Reconstructive Surgery
- Children's Pulmonology
- Children's Radiology
- Children's Rehabilitation
Our Providers who practice at this location:
| Provider | Specialty Keywords | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Kristine Beattie, MS, CCC-SLPSpecialties:
Children's Speech Language Pathology
View Practice Locations
Practice Locations:
|
modified barium swallow study, communication aids, auditory rehabilitation, oral myofunctional, cleft palate, swallowing, voice, resonance disorder, language disorder, pediatric feeding disorders, delay disorder, childrens speech language pathology, language delay, cognition, dyslexia, feeding, pediatric dysphagia, therapy, pediatric speech therapy, developmental delay, oral motor, language, communication barriers, pediatric speech therapist, pediatric speech language pathology, stuttering, pedatric language therapy, food aversion disorder, speech, cognitive disorders, alternative communication, pediatric speech pathologist, ent speech language pathology, aac device, children speech language pathology, ent slp, augmentative communication, language development, dysphagia, speech language delay, feeding disorder, pediatric language pathologist, articulation disorder | ||||||||||||||
|
Practice Locations:
|
|||||||||||||||
|
Practice Locations:
|
mutation, molecular genetics, metabolism, nipt, gene duplication, genes, medical genetics, genomics, dna, hereditary, children genetics, geneticists, genetic counselor, genome, genetics, microarray, chromosomes, congenital anomaly, recurrence risk, dysmorphology, array, geneticist, exome, rare disease, metabolic disorder, variant, inherited, chromosome, karyotype, gene, pediatric genetics, genomic, genetic testing, gene deletion, genetic, familial, childrens genetics | ||||||||||||||
|
Practice Locations:
|
pediatric cardio, pediatric abnormal heart beat, congenital heart failure, pediatric ekg, fetal arrhythmia, children's cardio, pediatric cardiac surgery, pediatric interventionalist, cardiology, children's cardiac, murmur, congenital cardiologist, pediatric cardiac, pediatric passing out, fetal cardiac, pediatric heart failure, fetal heart, pediatric mri, kid heart, children cardiology, cardiac, pediatric echocardiogram, pediatric hypertension, pediatric arrhythmia, pediatric palpitations, pediatric interventional, congenital, pediatric heart transplant, pediatric heart, congenital cardiology, baby heart, fetal cardiologist, congenital cardiac, cardiomyopathy, pediatric chest pain, pediatric cardiology, kid cardiac, heart, childrens cardiology, children's heart, pediatric heart problem, pediatric syncope, chf, cardio, pediatric fatigue, pediatric electrophysiologist, pediatric electrophysiology, pediatric high blood pressure | ||||||||||||||
|
Practice Locations:
|
mutation, molecular genetics, metabolism, nipt, gene duplication, genes, medical genetics, genomics, dna, hereditary, children genetics, geneticists, genetic counselor, genome, genetics, microarray, chromosomes, congenital anomaly, recurrence risk, dysmorphology, array, geneticist, exome, rare disease, metabolic disorder, variant, inherited, chromosome, karyotype, gene, pediatric genetics, genomic, genetic testing, gene deletion, genetic, familial, childrens genetics | ||||||||||||||
|
Practice Locations:
|
pediatric cardio, pediatric abnormal heart beat, congenital heart failure, pediatric ekg, fetal arrhythmia, children's cardio, pediatric cardiac surgery, pediatric interventionalist, cardiology, children's cardiac, murmur, congenital cardiologist, pediatric cardiac, pediatric passing out, fetal cardiac, pediatric heart failure, fetal heart, pediatric mri, kid heart, children cardiology, cardiac, pediatric echocardiogram, pediatric hypertension, pediatric arrhythmia, pediatric palpitations, pediatric interventional, congenital, pediatric heart transplant, pediatric heart, congenital cardiology, baby heart, fetal cardiologist, congenital cardiac, cardiomyopathy, pediatric chest pain, pediatric cardiology, kid cardiac, heart, childrens cardiology, children's heart, pediatric heart problem, pediatric syncope, chf, cardio, pediatric fatigue, pediatric electrophysiologist, pediatric electrophysiology, pediatric high blood pressure | ||||||||||||||
|
Practice Locations:
|
|||||||||||||||
|
Practice Locations:
|
add, pediatric child development, psychologist, pediatric, childhood, child psychology, learning, adhd, childrens child development, development, children's child development, growth, children child development | ||||||||||||||
|
Practice Locations:
|
pediatric cardio, pediatric abnormal heart beat, congenital heart failure, pediatric ekg, fetal arrhythmia, children's cardio, pediatric cardiac surgery, pediatric interventionalist, cardiology, children's cardiac, murmur, congenital cardiologist, pediatric cardiac, pediatric passing out, fetal cardiac, pediatric heart failure, fetal heart, pediatric mri, kid heart, children cardiology, cardiac, pediatric echocardiogram, pediatric hypertension, pediatric arrhythmia, pediatric palpitations, pediatric interventional, congenital, pediatric heart transplant, pediatric heart, congenital cardiology, baby heart, fetal cardiologist, congenital cardiac, cardiomyopathy, pediatric chest pain, pediatric cardiology, kid cardiac, heart, childrens cardiology, children's heart, pediatric heart problem, pediatric syncope, chf, cardio, pediatric fatigue, pediatric electrophysiologist, pediatric electrophysiology, pediatric high blood pressure | ||||||||||||||
|
Practice Locations:
|
losing hearing, hearing assist, hearing screening, retrocochlear hearing loss, deaf, earmold, cochlea, sensorineural hearing loss, ears ringing, hearing loss, pediatric audiology, hearing, losing balance, ear plugs, falling, hearing test, newborn hearing screen failed, audiometry, bone conduction implant, ear monitor, hearing protection, baha, audiologist, hearing specialist, psap, childrens audiology, balance loss, ringing ears, ent, ent audiology, hearing disorders, hearing damage, falls, tinnitus, ear, hearing implant, balance problems, hyperacusis, ear problems, ent audiologist, ear impression, hearing aid, listening device, deafness, atresia, microtia, cochlear implant, ear sensitivity, pediatric otolaryngology, noise exposure, meniere's disease, bad hearing, balance, hearing help, conductive, hearing problem, pediatric otolaryngologist, earpiece, ear protection, vertigo, hearing screen failed, pediatric audiologist, children audiology, hearing disorders, sensorineural hearing loss, balance loss, hyperacusis, presbycusis hearing loss, ent audiology, audiometry, hearing aid, losing hearing, meniere's disease, audiologist, balance problems, ear plugs, hearing, hearing screen failed, hearing loss, hearing problem, ears ringing, hearing assist, otolaryngologist, earpiece, bad hearing, ear monitor, cochlear implant, hearing screening, deafness, hearing damage, retrocochlear hearing loss, losing balance, earmold, ear sensitivity, balance, hearing help, noise exposure, bone conduction implant, baha, ear impression, hearing specialist, hearing protection, ent audiologist, ringing ears, conductive, vertigo, dizziness, cochlea, psap, falling, hearing test, falls, ear problems, hearing implant, listening device, tinnitus, ear, otolaryngology, bad hearing, ear protection, deaf, ent | ||||||||||||||
Ian C. Hoppe, MDSpecialties:
Plastic Surgery, Craniofacial and Trauma Surgery, Children's Craniofacial and Trauma Surgery, General Reconstruction, Skin Cancer Surgery, Children's Plastic and Reconstructive Surgery
View Practice Locations
Practice Locations:
|
children's general plastic surgery, children general plastic surgery, pediatric general plastic surgery, childrens general plastic surgery, childrens craniofacial and trauma surgery, children's craniofacial and trauma surgery, children craniofacial and trauma surgery, pediatric craniofacial and trauma surgery, adult craniofacial and trauma surgery, pediatric craniofacial and trauma surgery, reconstructive, face, children craniofacial and trauma surgery, childrens craniofacial and trauma surgery, cleft lip, childrens plastic and reconstructive surgery, children reconstructive surgery, pediatric reconstructive surgery, children's plastic surgeon, pediatric plastic and reconstructive surgery, pediatric plastic surgery, pediatric plastic surgeon, craniofacial, children plastic and reconstructive surgery, hand, childrens plastic surgery, children's reconstructive surgery, general, childrens reconstructive surgery, children plastic surgery, childrens plastic surgeon, children's plastic surgery, plastic | ||||||||||||||
Laura Humphries, MDSpecialties:
Plastic Surgery, Advanced Wound Care, Craniofacial and Trauma Surgery, Children's Craniofacial and Trauma Surgery, Skin Cancer Surgery, Plastic, Hand, Craniofacial and Reconstructive Surgery, Cosmetic Surgery, Children's Plastic and Reconstructive Surgery, General and Reconstructive Microsurgery, Head and Neck Reconstruction
View Practice Locations
Practice Locations:
|
children's general plastic surgery, children general plastic surgery, pediatric general plastic surgery, childrens general plastic surgery, burn, pediatric advanced wound care, childrens advanced wound care, wound, children's advanced wound care, scars, children advanced wound care, childrens craniofacial and trauma surgery, children's craniofacial and trauma surgery, children craniofacial and trauma surgery, pediatric craniofacial and trauma surgery, adult craniofacial and trauma surgery, pediatric craniofacial and trauma surgery, reconstructive, face, children craniofacial and trauma surgery, childrens craniofacial and trauma surgery, cleft lip, laser lipo, trigger finger, cosmetic, eye lift, neck lift, breast reduction, breast augmentation, facelift, liposuction cost, breast lift, tummy tuck, rhinoplasty, abdominoplasty, blepharoplasty, childrens plastic and reconstructive surgery, children reconstructive surgery, pediatric reconstructive surgery, children's plastic surgeon, pediatric plastic and reconstructive surgery, pediatric plastic surgery, pediatric plastic surgeon, craniofacial, children plastic and reconstructive surgery, hand, childrens plastic surgery, children's reconstructive surgery, general, childrens reconstructive surgery, children plastic surgery, childrens plastic surgeon, children's plastic surgery, plastic, plastic surgery | ||||||||||||||
Thy N. Huynh, MDSpecialties:
Skin of Color Dermatology, Children's Dermatology, Dermatology
View Practice Locations
Practice Locations:
|
acne, scarring, keloid, skin doctor, dermatitis, lymphoma, eczema, scars, hyperpigmentation, skin infection, acne scars, mole removal, rash, acral melanoma, african american, face, pimples, granulomatous diseases, skin pigment, mole, itchy skin, skin damage, hives, mycosis fungoides, sarcoidosis, skin, psoriasis, derm, skin help, skin problems, dermatologist, skin rash, vitiligo, melasma, acne keloidalis nuchae, pseudofolliculitis barbae, hypopigmentation, age spots, children dermatology, childrens dermatology, dermatologist, eczema, itchy skin, cutaneous melanoma, skin problems, psoriasis, pimples, acne, hives, derm, cutaneous lupus, pediatric dermatologist, skin doctor, skin rash, skin infection, cutaneous lymphoma, rosacea, vitiligo, pediatric dermatology, skin help, rash, wart, skin damage, radiesse, skin cancer screening, keloid, skin care, skincare, hyperhidrosis, dermatitis, hemangioma, skin, hives, chemical peel, skin rash, skin care, skin cancer, dermatitis, skin help, dermatologist, acne scars, psoriasis, scleroderma, hyperhidrosis, mole, rash, skin problems, cutaneous lymphoma, skin aging, skincare, wrinkles, spider veins, scupltra, face, acne, facial hair, melanoma, skin, vitiligo, vasculitis, cutaneous lupus, mole removal, shingles, lichen planus, fillers, lip cancer, fine lines, skin cancer screening, derm, pimples, radiesse, itchy skin, skin infection, wart, keloid, eczema, juvederm, cutaneous melanoma, restylane, mohs surgery, microdermabrasion, varicose veins, skin damage, rosacea, laser, sun damage | ||||||||||||||
|
Practice Locations:
|
CF, childrens pulmonology, pulmonologist, cystic fibrosis, pediatric, pulmonary, pediatric pulmonology, children pulmonology, pulmonology | ||||||||||||||
Leila M. Lanning, MSN, FNP-BCSpecialties:
Plastic Surgery, Children's Plastic and Reconstructive Surgery
View Practice Locations
Practice Locations:
|
children's general plastic surgery, children general plastic surgery, pediatric general plastic surgery, childrens general plastic surgery, childrens plastic and reconstructive surgery, children reconstructive surgery, pediatric reconstructive surgery, children's plastic surgeon, pediatric plastic and reconstructive surgery, pediatric plastic surgery, pediatric plastic surgeon, craniofacial, children plastic and reconstructive surgery, hand, childrens plastic surgery, children's reconstructive surgery, general, childrens reconstructive surgery, children plastic surgery, childrens plastic surgeon, children's plastic surgery, plastic | ||||||||||||||
|
Practice Locations:
|
CF, childrens pulmonology, pulmonologist, cystic fibrosis, pediatric, pulmonary, pediatric pulmonology, children pulmonology, pulmonology | ||||||||||||||
|
Practice Locations:
|
|||||||||||||||
Jenna L. Nassar, MS, CCC-SLPSpecialties:
Children's Speech Language Pathology
View Practice Locations
Practice Locations:
|
modified barium swallow study, communication aids, auditory rehabilitation, oral myofunctional, cleft palate, swallowing, voice, resonance disorder, language disorder, pediatric feeding disorders, delay disorder, childrens speech language pathology, language delay, cognition, dyslexia, feeding, pediatric dysphagia, therapy, pediatric speech therapy, developmental delay, oral motor, language, communication barriers, pediatric speech therapist, pediatric speech language pathology, stuttering, pedatric language therapy, food aversion disorder, speech, cognitive disorders, alternative communication, pediatric speech pathologist, ent speech language pathology, aac device, children speech language pathology, ent slp, augmentative communication, language development, dysphagia, speech language delay, feeding disorder, pediatric language pathologist, articulation disorder | ||||||||||||||
|
Practice Locations:
|
CF, childrens pulmonology, pulmonologist, cystic fibrosis, pediatric, pulmonary, pediatric pulmonology, children pulmonology, pulmonology, cpap, apnea, insomnia, snoring | ||||||||||||||
|
Practice Locations:
|
modified barium swallow study, communication aids, auditory rehabilitation, oral myofunctional, cleft palate, swallowing, voice, resonance disorder, language disorder, pediatric feeding disorders, delay disorder, childrens speech language pathology, language delay, cognition, dyslexia, feeding, pediatric dysphagia, therapy, pediatric speech therapy, developmental delay, oral motor, language, communication barriers, pediatric speech therapist, pediatric speech language pathology, stuttering, pedatric language therapy, food aversion disorder, speech, cognitive disorders, alternative communication, pediatric speech pathologist, ent speech language pathology, aac device, children speech language pathology, ent slp, augmentative communication, language development, dysphagia, speech language delay, feeding disorder, pediatric language pathologist, articulation disorder | ||||||||||||||
|
Practice Locations:
|
losing hearing, hearing assist, hearing screening, retrocochlear hearing loss, deaf, earmold, cochlea, sensorineural hearing loss, ears ringing, hearing loss, pediatric audiology, hearing, losing balance, ear plugs, falling, hearing test, newborn hearing screen failed, audiometry, bone conduction implant, ear monitor, hearing protection, baha, audiologist, hearing specialist, psap, childrens audiology, balance loss, ringing ears, ent, ent audiology, hearing disorders, hearing damage, falls, tinnitus, ear, hearing implant, balance problems, hyperacusis, ear problems, ent audiologist, ear impression, hearing aid, listening device, deafness, atresia, microtia, cochlear implant, ear sensitivity, pediatric otolaryngology, noise exposure, meniere's disease, bad hearing, balance, hearing help, conductive, hearing problem, pediatric otolaryngologist, earpiece, ear protection, vertigo, hearing screen failed, pediatric audiologist, children audiology, hearing disorders, sensorineural hearing loss, balance loss, hyperacusis, presbycusis hearing loss, ent audiology, audiometry, hearing aid, losing hearing, meniere's disease, audiologist, balance problems, ear plugs, hearing, hearing screen failed, hearing loss, hearing problem, ears ringing, hearing assist, otolaryngologist, earpiece, bad hearing, ear monitor, cochlear implant, hearing screening, deafness, hearing damage, retrocochlear hearing loss, losing balance, earmold, ear sensitivity, balance, hearing help, noise exposure, bone conduction implant, baha, ear impression, hearing specialist, hearing protection, ent audiologist, ringing ears, conductive, vertigo, dizziness, cochlea, psap, falling, hearing test, falls, ear problems, hearing implant, listening device, tinnitus, ear, otolaryngology, bad hearing, ear protection, deaf, ent | ||||||||||||||
|
Practice Locations:
|
mutation, molecular genetics, metabolism, nipt, gene duplication, genes, medical genetics, genomics, dna, hereditary, children genetics, geneticists, genetic counselor, genome, genetics, microarray, chromosomes, congenital anomaly, recurrence risk, dysmorphology, array, geneticist, exome, rare disease, metabolic disorder, variant, inherited, chromosome, karyotype, gene, pediatric genetics, genomic, genetic testing, gene deletion, genetic, familial, childrens genetics | ||||||||||||||
|
Practice Locations:
|
|||||||||||||||
|
Practice Locations:
|
losing hearing, hearing assist, hearing screening, retrocochlear hearing loss, deaf, earmold, cochlea, sensorineural hearing loss, ears ringing, hearing loss, pediatric audiology, hearing, losing balance, ear plugs, falling, hearing test, newborn hearing screen failed, audiometry, bone conduction implant, ear monitor, hearing protection, baha, audiologist, hearing specialist, psap, childrens audiology, balance loss, ringing ears, ent, ent audiology, hearing disorders, hearing damage, falls, tinnitus, ear, hearing implant, balance problems, hyperacusis, ear problems, ent audiologist, ear impression, hearing aid, listening device, deafness, atresia, microtia, cochlear implant, ear sensitivity, pediatric otolaryngology, noise exposure, meniere's disease, bad hearing, balance, hearing help, conductive, hearing problem, pediatric otolaryngologist, earpiece, ear protection, vertigo, hearing screen failed, pediatric audiologist, children audiology | ||||||||||||||
|
Practice Locations:
|
|||||||||||||||
|
Practice Locations:
|
pediatric cardio, pediatric abnormal heart beat, congenital heart failure, pediatric ekg, fetal arrhythmia, children's cardio, pediatric cardiac surgery, pediatric interventionalist, cardiology, children's cardiac, murmur, congenital cardiologist, pediatric cardiac, pediatric passing out, fetal cardiac, pediatric heart failure, fetal heart, pediatric mri, kid heart, children cardiology, cardiac, pediatric echocardiogram, pediatric hypertension, pediatric arrhythmia, pediatric palpitations, pediatric interventional, congenital, pediatric heart transplant, pediatric heart, congenital cardiology, baby heart, fetal cardiologist, congenital cardiac, cardiomyopathy, pediatric chest pain, pediatric cardiology, kid cardiac, heart, childrens cardiology, children's heart, pediatric heart problem, pediatric syncope, chf, cardio, pediatric fatigue, pediatric electrophysiologist, pediatric electrophysiology, pediatric high blood pressure, baby heart, pediatric fetal cardiology, fetus, childrens fetal cardiology, children's fetal cardiology, children fetal cardiology | ||||||||||||||
|
Practice Locations:
|
CF, childrens pulmonology, pulmonologist, cystic fibrosis, pediatric, pulmonary, pediatric pulmonology, children pulmonology, pulmonology | ||||||||||||||
|
Practice Locations:
|
pediatric cardio, pediatric abnormal heart beat, congenital heart failure, pediatric ekg, fetal arrhythmia, children's cardio, pediatric cardiac surgery, pediatric interventionalist, cardiology, children's cardiac, murmur, congenital cardiologist, pediatric cardiac, pediatric passing out, fetal cardiac, pediatric heart failure, fetal heart, pediatric mri, kid heart, children cardiology, cardiac, pediatric echocardiogram, pediatric hypertension, pediatric arrhythmia, pediatric palpitations, pediatric interventional, congenital, pediatric heart transplant, pediatric heart, congenital cardiology, baby heart, fetal cardiologist, congenital cardiac, cardiomyopathy, pediatric chest pain, pediatric cardiology, kid cardiac, heart, childrens cardiology, children's heart, pediatric heart problem, pediatric syncope, chf, cardio, pediatric fatigue, pediatric electrophysiologist, pediatric electrophysiology, pediatric high blood pressure, baby heart, pediatric fetal cardiology, fetus, childrens fetal cardiology, children's fetal cardiology, children fetal cardiology | ||||||||||||||
|
Practice Locations:
|
mutation, molecular genetics, metabolism, nipt, gene duplication, genes, medical genetics, genomics, dna, hereditary, children genetics, geneticists, genetic counselor, genome, genetics, microarray, chromosomes, congenital anomaly, recurrence risk, dysmorphology, array, geneticist, exome, rare disease, metabolic disorder, variant, inherited, chromosome, karyotype, gene, pediatric genetics, genomic, genetic testing, gene deletion, genetic, familial, childrens genetics | ||||||||||||||
|
Practice Locations:
|
CF, childrens pulmonology, pulmonologist, cystic fibrosis, pediatric, pulmonary, pediatric pulmonology, children pulmonology, pulmonology | ||||||||||||||
Rachel S. Tyrone, PhD, CCC-SLPSpecialties:
Children's Speech Language Pathology
View Practice Locations
Practice Locations:
|
modified barium swallow study, communication aids, auditory rehabilitation, oral myofunctional, cleft palate, swallowing, voice, resonance disorder, language disorder, pediatric feeding disorders, delay disorder, childrens speech language pathology, language delay, cognition, dyslexia, feeding, pediatric dysphagia, therapy, pediatric speech therapy, developmental delay, oral motor, language, communication barriers, pediatric speech therapist, pediatric speech language pathology, stuttering, pedatric language therapy, food aversion disorder, speech, cognitive disorders, alternative communication, pediatric speech pathologist, ent speech language pathology, aac device, children speech language pathology, ent slp, augmentative communication, language development, dysphagia, speech language delay, feeding disorder, pediatric language pathologist, articulation disorder | ||||||||||||||
Marc E. Walker, MDSpecialties:
Plastic Surgery, Children's Hand Surgery, Skin Cancer Surgery, Hand Surgery and Trauma, Cosmetic Surgery, Children's Orthopaedics, Body Contouring, Children's Plastic and Reconstructive Surgery, Orthopaedic Hand and Upper Extremity, Breast Reconstruction, General and Reconstructive Microsurgery
View Practice Locations
Practice Locations:
|
children's general plastic surgery, children general plastic surgery, pediatric general plastic surgery, childrens general plastic surgery, fingers, reconstructive, children hand surgery, childrens hand surgery, pediatric hand surgery, children's hand surgery and trauma, plastic, pediatric hand surgery and trauma, reconstructive, childrens hand surgery and trauma, children hand surgery and trauma, fingers, pediatric orthopaedics, children's orthpedics, childrens orthopedics, children orthopaedics, pediatric orthopedics, childrens orthopaedics, childrens orthopedics, childrens plastic and reconstructive surgery, children reconstructive surgery, pediatric reconstructive surgery, children's plastic surgeon, pediatric plastic and reconstructive surgery, pediatric plastic surgery, pediatric plastic surgeon, craniofacial, children plastic and reconstructive surgery, hand, childrens plastic surgery, children's reconstructive surgery, general, childrens reconstructive surgery, children plastic surgery, childrens plastic surgeon, children's plastic surgery, plastic, fat transfer breast reconstruction, ms-tram flap, diep flap, nipple reconstruction, fat grafting, implant breast reconstruction, nipple-areola tattoo, breast reduction, plastic surgery | ||||||||||||||
Whitney A. Wallace, MS, CCC-SLPSpecialties:
Children's Speech Language Pathology
View Practice Locations
Practice Locations:
|
modified barium swallow study, communication aids, auditory rehabilitation, oral myofunctional, cleft palate, swallowing, voice, resonance disorder, language disorder, pediatric feeding disorders, delay disorder, childrens speech language pathology, language delay, cognition, dyslexia, feeding, pediatric dysphagia, therapy, pediatric speech therapy, developmental delay, oral motor, language, communication barriers, pediatric speech therapist, pediatric speech language pathology, stuttering, pedatric language therapy, food aversion disorder, speech, cognitive disorders, alternative communication, pediatric speech pathologist, ent speech language pathology, aac device, children speech language pathology, ent slp, augmentative communication, language development, dysphagia, speech language delay, feeding disorder, pediatric language pathologist, articulation disorder | ||||||||||||||
|
Practice Locations:
|
pediatric cardio, pediatric abnormal heart beat, congenital heart failure, pediatric ekg, fetal arrhythmia, children's cardio, pediatric cardiac surgery, pediatric interventionalist, cardiology, children's cardiac, murmur, congenital cardiologist, pediatric cardiac, pediatric passing out, fetal cardiac, pediatric heart failure, fetal heart, pediatric mri, kid heart, children cardiology, cardiac, pediatric echocardiogram, pediatric hypertension, pediatric arrhythmia, pediatric palpitations, pediatric interventional, congenital, pediatric heart transplant, pediatric heart, congenital cardiology, baby heart, fetal cardiologist, congenital cardiac, cardiomyopathy, pediatric chest pain, pediatric cardiology, kid cardiac, heart, childrens cardiology, children's heart, pediatric heart problem, pediatric syncope, chf, cardio, pediatric fatigue, pediatric electrophysiologist, pediatric electrophysiology, pediatric high blood pressure |
Our Clinical Trials offered at this location:
Researchers at UMMC are committed to discovering innovative ways to prevent and treat the diseases that affect our daily lives. Clinical research studies play a vital role in the advancement of medicine and can improve the well-being of our families, friends, communities, and future generations. In this way, participation in clinical research studies furthers our vision to create "a healthier Mississippi."
Partnering with UMMC’s researchers may have many advantages, including:
- Gaining access to investigational treatments
- Increasing knowledge about your own health
- Giving the gift of improved health to our communities and future generations
- Contributing to the advancement of science by helping researchers learn more about how the human body and mind work or by helping find a cure or better treatments for diseases
| Clinical Trials | Publish Date | Description | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A Study Evaluating the Efficacy, Safety, Pharmacodynamics, and Pharmacokinetics of Oxybutynin Chloride 10% Gel for the Treatment of Detrusor Overactivity Associated With a Neurological Condition in Pediatric PatientsIRB Number: 2017-0099
Published: May 28, 2019
View Locations
Clinical Trial Locations:
|
20190528152221 |
This study will evaluate the effectiveness, safety and skin tolerance of oxybutynin chloride get compared to placebo in pediatric patients during the first 6 weeks of a 14 week open-label treatment period.<br> neuroscience;pediatrics OG09002 Cathy Hudgins cbean Neurosciences Pediatrics |
||||||||||
A double-blind, randomised, placebo-controlled, parallel group trial to evaluate the efficacy and safety of empagliflozin and linagliptin over 26 weeks, with a double-blind active treatment safety extension period up to 52 weeks, in children and adolescents with type 2 diabetes mellitusIRB Number: 2019-0166
Published: August 26, 2019
View Locations
Clinical Trial Locations:
|
20190826150654 |
This study will assess the effectiveness and long term safety of empagliflozin and linagliptin versus placebo in children and adolescents with type 2 diabetes mellitus. pediatrics 1218-0091 Angelena Sharp ndixit Palliative Care |
||||||||||
A Phase 2/3 Randomized, Double-blind, Palivizumab-controlled Study to Evaluate the Safety of MEDI8897, a Monoclonal Antibody With an Extended Half-life Against Respiratory Syncytial Virus, in High-risk Children (MEDLEY)IRB Number: 2019-0209
Published: November 25, 2019
View Locations
Clinical Trial Locations:
|
20191125103217 |
This study will evaluate the safety and tolerability of MEDI8897 compared to palivizumab in preterm infants entering their first RSV season and children with chronic lung disease or congenital heart disease entering their first and second RSV season. pediatrics;women's health;lungs D5290C00005 Sandra Tyler abhatt Lungs/Breathing Pediatrics Women's Health |
||||||||||
A Phase 3, Open-Label Study Evaluating the Long-term Safety and Efficacy of VX-659 Combination Therapy in Subjects with Cystic Fibrosis Who Are Homozygous or Heterozygous for the F508del MutationIRB Number: 2018-0129
Published: June 27, 2019
View Locations
Clinical Trial Locations:
|
20190627111426 |
This study will evaluate the long-term effects of an experimental drug in Cystic Fibrosis patients who completed a previous Vertex study. lungs;pediatrics VX17-659-105 Sandra Tyler jspurzem Digestive Conditions Lungs/Breathing Pediatrics |
||||||||||
A Phase 3b, Multi-center, Randomized, Double-blind, Placebo controlled, Parallel-group Trial with an Open-label Extension Phase to demonstrate that the efficacy of avatrombopag is superior to placebo for the treatment of pediatric subjects with ITP of ≥6 months duration who have had an insufficient response to a previous treatment.IRB Number: 2020V0152
Published: October 20, 2021
View Locations
Clinical Trial Locations:
|
20211020143313 |
This Phase 3b, multi-center, randomized, double-blind, placebo-controlled, parallel-group study in pediatric subjects who have had a diagnosis of ITP for ≥6 months, includes a 12 week Core Phase followed by a 2 year open-label Extension Phase. pediatrics AVA-PED-301 Rhonda Aikens ddavis7 Pediatrics |
||||||||||
A Pilot Study of Rituximab (RTX) and Third Party Latent Membrane Protein (LMP)-specific Cytotoxic T-Lymphocytes (LMP-TC, IND# 17068) in Pediatric Solid Organ Recipients (SOT) with EBV-Positive CD20-Positive Post-Transplant Lymphoproliferative Disease (PTLD)IRB Number: 2017-0307
Published: May 28, 2019
View Locations
Clinical Trial Locations:
|
20190528151722 |
This pilot study is testing the drug rituximab and immune cells from donors to treat post-transplant lymphoproliferative disease in people after solid organ transplant.<br> pediatrics;surgery;transplant ANHL1522 Maggie Goad Betty H Melton Pediatrics Surgery Transplant |
||||||||||
A Randomized Trial of Post-Radiation Chemotherapy in Patients with Newly Diagnosed EpendymomaIRB Number: 2010-0098
Published: May 28, 2019
View Locations
Clinical Trial Locations:
|
20190528152445 |
The primary purpose of this study is to determine the event free survival and overall survival of children with completely resected ependymoma treated with post-operative conformal radiation therapy and then randomized to receive or not to receive four cycles of post radiation maintenance chemotherapy with vincristine, cisplatin, cyclophosphamide, and etoposide (VCEC). The secondary purpose of the study is to determine the event free survival and overall survival of children with incompletely resected ependymoma who are unable to achieve a complete response by a) post-operative chemotherapy or by b) second surgery who will then be non-randomly assigned to conformal radiation therapy followed by four cycles of maintenance chemotherapy (VCEC). <br> cancer;pediatrics ACNS0831 Leslie Johnson bstronach Cancer Pediatrics |
||||||||||
A randomized, double blind, parallel-group, placebo controlled study to evaluate the efficacy and safety of IBP-9414 in premature infants 500-1500g birth weight in the prevention of necrotizing enterocolitis - The Connection StudyIRB Number: 2019-0139
Published: June 24, 2019
View Locations
Clinical Trial Locations:
|
20190624155427 |
To evaluate the efficacy of IBP-9414 vs. placebo on the prevention of necrotizing enterocolitis
and on sustained feeding tolerance in very low birth weight premature infants, as well as the
safety of IBP-9414 vs. placebo. The study is powered on the necrotizing enterocolitis endpoint. pediatrics IBP-9414-020 Sandra Tyler mfamuyide Pediatrics |
||||||||||
A Randomized, Double-Blind, Controlled, Clinical Trial to Evaluate the Risk of Developing Essential Fatty Acid Deficiency in Pediatric Patients, Including Neonates, Receiving Either Clinolipid (liquid injectable emulsion, USP) 20% or Standard-of-Care soybean Oil-Based Lipid EmulsionIRB Number: 2020V0315
Published: July 01, 2021
View Locations
Clinical Trial Locations:
|
20210701141416 |
To evaluate the risk of developing EFAD in pediatric patients, including neonates, receiving either Clinolipid or standard-of-care soybean oil-based lipid emulsion (Intralipid) as a component of parenteral nutrition (PN) within the hospital setting from 7 to 90 days, inclusive. pediatrics 6344-001 Sandra Tyler abhatt Pediatrics |
||||||||||
A Study of Active Surveillance for Low Risk and A Randomized Trial of Carboplatin vs. Cisplatin for Standard Risk Pediatric and Adult Patients with Germ Cell TumorsIRB Number: 2017-0188
Published: May 28, 2019
View Locations
Clinical Trial Locations:
|
20190528152137 |
The goal of this study is to minimize the toxicity associated with treatment of low and standard risk germ cell tumors. <br> cancer;surgery;pediatrics AGCT1531 Maggie Goad Betty H Melton Cancer Pediatrics Surgery |
||||||||||
A Study of Brentuximab Vedotin for Newly Diagnosed High-Risk Classical Hodgkin Lymphoma (cHL)in Children and AdolescentsIRB Number: 2015-0102
Published: May 28, 2019
View Locations
Clinical Trial Locations:
|
20190528150417 |
This study is being done to look at the efficacy of a chemotherapy regimen (ABVE-PC) including Brentuximab vedotin (Bv) in high-risk cHL. <br> pediatrics;cancer AHOD1331 Jennifer Brumfield lmena Cancer Pediatrics |
||||||||||
A Study of Inotuzumab Ozogamicin (NSC#772518, IND# 133494) in Children and Young Adults with Relapsed or Refractory CD22+ B-Acute Lymphoblastic LeukemiaIRB Number: 2017-0198
Published: May 28, 2019
View Locations
Clinical Trial Locations:
|
20190528152120 |
This study is a single arm study to evaluate the toxicity and preliminary efficacy of inotuzumab ozogamicin in pediatric patients with CD22+ B-Acute Lymphoblastic Leukemia that is refractory or in second or greater relapse. <br> cancer;pediatrics AALL1621 Maggie Goad Betty H Melton Cancer Pediatrics |
||||||||||
A Study of JAK1/JAK2 Inhibitor Ruxolitinib with Chemotherapy in Children with De Novo High-Risk CRLF2-Rearranged and/or JAK Pathway-Mutant Acute Lymphoblastic LeukemiaIRB Number: 2016-0212
Published: May 28, 2019
View Locations
Clinical Trial Locations:
|
20190528152839 |
This is a non-randomized study looking at ruxolitinib in combination with a standard mult-agent chemotherapy regimen for the treatment of B-Acute Lymphoblastic Leukemia (B-ALL). <br> cancer;pediatrics AALL1521 Maggie Goad Betty H. Melton Cancer Pediatrics |
||||||||||
A Study of Reduced Therapy for Newly Diagnosed Average-Risk WNT-Driven Medulloblastoma PatientsIRB Number: 2017-0271
Published: May 28, 2019
View Locations
Clinical Trial Locations:
|
20190528151751 |
The overall goal of this study is to find out if a reduced dose of radiation to the whole brain and spine and less chemotherapy can be given to children and young adults with WNT subtype medulloblastoma without increasing the risk of the tumor coming back. The combination of a reduction in radiation therapy and chemotherapy is experimental.<br> pediatrics;cancer ACNS1422 Maggie Goad Betty H Melton Cancer Pediatrics |
||||||||||
A Study of Veliparib (ABT-888, IND# 139199) and Local Irradiation, Followed by Maintenance Veliparib and Temozolomide, in Patients with Newly Diagnosed High-Grade Glioma (HGG) without H3 K27M or BRAF MutationsIRB Number: 2019-0016
Published: May 28, 2019
View Locations
Clinical Trial Locations:
|
20190528151454 |
The goal of the study is to see if using veliparib with radiation therapy followed by veliparib with temozolomide during maintenance therapy will be better than treatment with other therapies that do not contain veliparib in helping to get rid of or shrink high-grade gliomas (HGGs).<br> cancer;pediatrics ACNS1721 Maggie Goad Betty H Melton Cancer Pediatrics |
||||||||||
A Study on the Safety and Efficacy of Apixaban for Thromboembolism Prevention versus No Systemic Anticoagulant Prophylaxis during Induction Chemotherapy in Children with Newly Diagnosed Acute Lymphoblastic Leukemia (ALL) or Lymphoma (T or B cell) Treated with Pegylated (PEG) L-asparaginaseIRB Number: 2015-0076
Published: May 28, 2019
View Locations
Clinical Trial Locations:
|
20190528152402 |
This study is looking at the safety and efficacy of giving an anticoagulant, apixaban, as prophylactic treatment to prevent the formation of clots/thrombus in patients with acute lymphoblastic leukemia and lymphoma.<br> cancer;pediatrics;leukemia;lymphoma ACCL1333/CV185-155 Theresa Hutson tsuzuki Cancer Pediatrics |
||||||||||
A Study to Evaluate the Efficacy and Safety of Intravenous L-citrulline for the Prevention of Clinical Sequelae of Acute Lung Injury induced by Cardiopulmonary Bypass in Pediatric Subjects Undergoing Surgery for Congenital Heart DefectsIRB Number: 2017-0315
Published: May 28, 2019
View Locations
Clinical Trial Locations:
|
20190528153343 |
This clinical trial is designed to determine how effictive L-Citrulline is for pediatric patients with heart defects that will need surgery and the use of bypass during the surgery. The primary objective of the study will be to determine if L-Citrulline ,given during surgery, reduces lung injury in pediatric patients.<br> pediatrics;surgery;heart CIT-003-01 Angelena Sharp mbtaylor Heart Health Pediatrics Surgery |
||||||||||
A Trial in Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia (Ph+ ALL) testing imatinib in combination with two different cytotoxic chemotherapy backbonesIRB Number: 2017-0239
Published: May 28, 2019
View Locations
Clinical Trial Locations:
|
20190528153354 |
The optimal treatment for PH+ ALL has not yet been determined. There is now general consensus among North American and European Childhood ALL treatment groups that Ph+ ALL patients with a favorable early response to the combination of chemotherapy and tyrosine kinase inhibitor (TKI) treatment can be treated without hematopoeitic stem cell transplant in first complete remission. Two different chemotherapy backbones have been used in combination with TKI therapy in recent North American and European pediatric Ph+ ALL trials. This study will compare those two chemotherapy backbones with the use of imatinib as TKI therapy to determine which chemotherapy backbone will have a higher disease free survival.<br> cancer;pediatrics AALL1631 Rachel Lowery Betty H. Melton Cancer Pediatrics |
||||||||||
A Trial of Accelerated versus Standard BEP Chemotherapy for Patients with Intermediate and Poor-risk Metastatic Germ Cell TumorsIRB Number: 2019-0014
Published: May 28, 2019
View Locations
Clinical Trial Locations:
|
20190528151540 |
The purpose of this study is to determine if accelerated BEP (Bleomycin, Etoposide, cisPlatin) is more effective but not significantly more toxic than standard BEP as first-line chemotherapy for patients with intermediate and poor-risk metastatic germ cell tumors (GCTs).<br> cancer AGCT1532 Maggie Goad Betty H Melton Cancer |
||||||||||
A Trial of Axitinib/Nivolumab Combination Therapy vs Single Agent Axitinib or Nivolumab for the Treatment of TFE/Translocation Renal Cell Carcinoma Across All Age GroupsIRB Number: 2019-0015
Published: May 28, 2019
View Locations
Clinical Trial Locations:
|
20190528133413 |
The purpose of this study is to learn more about how to treat translocation renal cell carcinoma (tRCC), and to find out what effects, good and/or bad, axinitib and nivolumab have on participants when the drugs are given alone or in combination.<br> cancer AREN1721 Maggie Goad Betty H Melton Cancer |
||||||||||
A Trial of Nivolumab + Brentuximab Vedotin for Children, Adolescents, and Young Adults with Relapsed/Refractory CD30+ classic Hodgkin Lymphoma after Failure of First-Line Therapy, followed by Brentuximab + Bendamustine for Participants with Suboptimal ResponseIRB Number: 2017-0165
Published: May 28, 2019
View Locations
Clinical Trial Locations:
|
20190528152157 |
This study is being done to look at the response rate and tolerability of nivolumab + brentuximab vedotin in patients with relapsed/refractory CD30+ classic Hodgkin Lymphoma after failure of first-line therapy. The study will also look at the response rate and tolerability of brentuximab + bendamustine in patients with suboptimal response to nivolumab + brentuximab therapy on this study.<br> cancer;pediatrics CA209744 Maggie Goad Betty H Melton Cancer Pediatrics |
||||||||||
A Trial to Evaluate the Safety and Efficacy of 2 Treatment Regimens of Aztreonam 75mg Powder and Solvent for Nebulizer Solution/ Aztreonam for Inhalation Solution (AZLI) in Pediatric Subjects with Cystic Fibrosis (CF) and New Onset Respiratory Tract Pseudomonas aeruginosa (PA) Infection/ ColonizationIRB Number: 2017-0246
Published: May 28, 2019
View Locations
Clinical Trial Locations:
|
20190528152058 |
This study will evaluate the safety and effectiveness of a 14-day course vs a 28-day course of Aztreonam (AZLI) in Cystic Fibrosis participants with new onset Pseudomonas aeruginosa (PA) infection.<br> pediatrics;genetics;lungs;breathing GS-US-205-1850 Takila Keys djosey Genetics Lungs/Breathing Pediatrics |
||||||||||
ADVL1711: A Phase 1/2 Study of Lenvatinib in Combination with Everolimus in Recurrent and Refractory Pediatric Solid Tumors, including CNS TumorsIRB Number: 2019-0228
Published: November 14, 2019
View Locations
Clinical Trial Locations:
|
20191114110810 |
In this study, the drugs lenvatinib and everolimus are being given in combination. The main purpose of this study is to study the effects of this combination of study drugs on the body; to assess the activity of study drugs in combination; to assess any shrinkage in tumor size; to determine what happens to the study drugs in the body (how they are absorbed, distributed, broken down, and excreted); to assess biomarkers (markers that may help researchers understand the disease and effectiveness of lenvatinib and everolimus) in blood and tumor tissues. cancer;pediatrics E7080-A001-216 Maggie Goad Betty H. Melton Cancer Pediatrics |
||||||||||
ADVL1921, PHASE 1 STUDY TO EVALUATE THE SAFETY AND PHARMACOKINETICS OF PALBOCICLIB (IBRANCE®) IN COMBINATION WITH IRINOTECAN AND TEMOZOLOMIDE IN PEDIATRIC PATIENTS WITH RECURRENT OR REFRACTORY SOLID TUMORSIRB Number: 2019-0115
Published: November 14, 2019
View Locations
Clinical Trial Locations:
|
20191114111935 |
This study is for children and adolescents with recurrent and refractory tumors. We will add an experimental drug, Palbociclib, to standard chemotherapy in the hopes it will shrink or get rid of the tumor for a time. pediatrics;cancer A5481092 Rachel Lowery Betty H Melton Cancer Pediatrics |
||||||||||
An Efficacy Study in Pediatric Subjects Requiring Anticoagulation for the Treatment of a Venous Thromboembolic EventIRB Number: 2016-0254
Published: May 28, 2019
View Locations
Clinical Trial Locations:
|
20190528152707 |
This study will assess the safety and effectiveness of Apixaban in pediatric participants when randomized using a 2 to 1 ratio to receive either apixaban or standard of care treatments for anticoagulation. <br> pediatrics B0661037/CV185-325 Angelena Sharp mbtaylor Pediatrics |
||||||||||
An intermediate access protocol for selumetinib for treatment of neurofibromatosis type 1 with inoperable, progressive/symptomatic plexiform neurofibromasIRB Number: 2019-0185
Published: June 17, 2020
View Locations
Clinical Trial Locations:
|
20200617112859 |
The purpose of this protocol is to provide potential treatment of neurofibromatosis type 1 (NF1) with progressive/symptomatic plexiform neurofibromas (PN), by using the study drug, Selumetinib. pediatrics;neuroscience;cancer D1346R00002 Jennifer Barnes manderson4 Cancer Neurosciences Pediatrics |
||||||||||
An Observational Disease and Clinical Outcomes Registry of Patients With Lysosomal Acid Lipase (LAL) DeficiencyIRB Number: 2023-65
Published: July 10, 2025
View Locations
Clinical Trial Locations:
|
20250710164611 |
<div style="box-sizing: border-box; margin-top: 0.5rem; font-weight: 700; font-size: 14px; color: #565c65; padding-bottom: 2px; border-bottom: 1px solid #dfe1e2; margin-bottom: 8px; text-transform: capitalize; font-family: Roboto, sans-serif; background-color: #ffffff;">Brief Summary</div><div style="box-sizing: border-box; margin-bottom: 20px; color: #171716; line-height: 1.62; font-family: Roboto, sans-serif; background-color: #ffffff;">This is an observational, multi-center, international disease registry designed to collect longitudinal data and create a knowledge base that will be utilized to improve the care and treatment of patients with LAL Deficiency. Participation in the Registry by both physicians and patients is voluntary.</div><div style="box-sizing: border-box; position: relative; width: 743px; flex: 0 1 auto; font-weight: 700; font-size: 14px; color: #565c65; padding-bottom: 2px; border-bottom: 1px solid #dfe1e2; margin-bottom: 8px; text-transform: capitalize; font-family: Roboto, sans-serif; background-color: #ffffff;">Detailed Description</div><div style="box-sizing: border-box; margin-bottom: 20px; color: #171716; line-height: 1.62; font-family: Roboto, sans-serif; background-color: #ffffff;"><p>Lysosomal Acid Lipase (LAL) Deficiency is a rare autosomal recessive lysosomal storage disorder (LSD) that is caused by a marked decrease of lysosomal acid lipase (LAL), the enzyme that breaks down cholesteryl esters and triglycerides in the lysosomes.</p><p>Lysosomal Acid Lipase Deficiency presenting in infants (historically called Wolman Disease) is a medical emergency with rapid disease progression over a period of weeks that is typically fatal within the first 6 months of life. More commonly, LAL Deficiency presents in children and adults and this presentation has been historically called Cholesteryl Ester Storage Disease (CESD). In general, data on the prevalence of LAL Deficiency are limited, and the overall prevalence of the disease in the population is unclear.</p><p>For all presentations, LAL Deficiency is associated with significant morbidity and mortality. Deficient LAL enzyme activity results in the lysosomal accumulation of cholesteryl esters and triglycerides. In the liver, this accumulation leads to hepatomegaly, increased hepatic fat content, transaminase elevation signaling chronic liver injury, and progression to fibrosis, cirrhosis, and complications of end stage liver disease. In the spleen, LAL Deficiency results in splenomegaly, anemia, and thrombocytopenia. Lipid accumulation in the intestinal wall leads to malabsorption and growth failure. Dyslipidemia is common with elevated low density lipoprotein (LDL) and triglycerides and low high density lipoprotein (HDL), associated with increased liver fat content and transaminase elevations. In addition to liver disease, patients with LAL Deficiency experience increased risk for cardiovascular disease and accelerated atherosclerosis.</p><p>The LAL Deficiency Registry is a global registry, established to help improve care for patients through improved understanding of the disease and long-term effectiveness of therapeutic interventions including sebelipase alfa.</p><p>As with other registries, which are becoming increasingly valuable for collecting information in large, heterogeneous, 'real world' populations, the LAL Deficiency Registry aims to provide evidence to help support patient care and inform clinical practice. This Registry is also being conducted, in part, to fulfill post-marketing commitments and requirements agreed to by the Sponsor as a condition for sebelipase alfa approval in the EU and the USA.</p></div> lipid;lipidoses;lipid metabolism;lal;lysosomal acid lipase;lysosomal acid lipase (lal) deficiency;lysosomal acid lipase deficiency;metabolic disease;lal deficiency ALX-LALD-501 Sarah Jones, MD smjones Endocrinology/Diabetes Liver Diseases Palliative Care Pediatrics |
||||||||||
An Open-Label, Multicenter Study of RC-P in Patients with Acute Lymphoblastic Leukemia (ALL)/Lymphoblastic Lymphoma (LBL) Following Hypersensitivity to E. coli-derived AsparaginasesIRB Number: 2019-0282
Published: January 27, 2020
View Locations
Clinical Trial Locations:
|
20200127132950 |
This study is being done to learn more about how the body handles the drug RC-P and to learn about the side effects. cancer IND 129622 Julie Hornaday Betty H Melton Cancer |
||||||||||
APOL1 Long-term Kidney Transplantation Outcomes NetworkIRB Number: 2019-0333
Published: January 27, 2020
View Locations
Clinical Trial Locations:
|
20200127123701 |
This study aims to prospectively assess the effects of genetic variants on outcomes for kidneys from donors with recent African ancestry and the recipients of such kidneys after deceased- and living-donor renal transplantation. kidney conditions;kidney disease 2019-0333 Amy Wigglesworth jjwynn Kidney/Renal Conditions |
||||||||||
D5290C00004- A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of MEDI8897, a Monoclonal Antibody With an Extended Half-Life Against Respiratory Syncytial Virus, In Healthy Late Preterm and Term Infants (MELODY)IRB Number: 2019-0204
Published: November 25, 2019
View Locations
Clinical Trial Locations:
|
20191125104508 |
This study will access the safety and effectiveness of a single injection of MEDI8897 compared to placebo in infants >35 weeks gestational age in their first RSV season. breathing;lungs;pediatrics;women's health D5290C00004 Sandra Tyler abhatt Lungs/Breathing Pediatrics Women's Health |
||||||||||
Effects of an Exclusive Human Milk Diet on Enteral Feeding Outcomes of Neonates with Congenital Gastrointestinal DisordersIRB Number: 2019-0131
Published: August 26, 2019
View Locations
Clinical Trial Locations:
|
20190826142052 |
This study will identify whether an exclusive human milk diet (EHMD) would improve outcomes in patients with congenital gastrointestinal disorders (CGD) by facilitating an earlier transition off of parental nutrition (PN) when compared to the current standard of a partial human milk or exclusive formula diets. pediatrics;women's health Human Milk Diet/CGD Chelsea Giachelli abhatt Digestive Conditions Pediatrics Women's Health |
||||||||||
Expanded Indications in the MED-EL Pediatric Cochlear Implant PopulationIRB Number: 2019-0096
Published: August 26, 2019
View Locations
Clinical Trial Locations:
|
20190826092534 |
The study will look at the benefits of cochlear implantation in children aged 7 months up to 5 years, 11 months of age. The goal will be to expand FDA indications for implants in two groups: children less than 12 months of age, and children over 12 months with residual low-frequency hearing. pediatrics G180269 Victoria Gonzalez jcarron Hearing Pediatrics |
||||||||||
EYP-DIP-001: A Phase 3/4, Prospective, Randomized, Active Treatment-Controlled, Parallel-Design, Multicenter Study to Evaluate the Safety of DEXYCU for the Treatment of Inflammation Following Ocular Surgery for Childhood CataractIRB Number: 2021V0822
Published: October 04, 2022
View Locations
Clinical Trial Locations:
|
20221004214522 |
The purpose of this study is to test the safety of an investigational drug product, (DEXYCU), in children to treat eye inflammation (redness) caused by cataract surgery. cataract;dexycu (dexamethasone intraocular suspension) EYP-DIP-001 Morgan Ladner HongVan Le Eyes/Vision Pediatrics Surgery |
||||||||||
Health Effects after Anthracycline and Radiation Therapy (HEART): Dexrazoxane and Prevention of Anthracycline-related CardiomyopathyIRB Number: 2013-0247
Published: May 28, 2019
View Locations
Clinical Trial Locations:
|
20190528151414 |
<p>The major goals of the study are to:</p><ol><li>see if patients treated on the 3 targeted studies who received Zinecard have better heart function compared to those who did not receive Zinecard.</li><li>see if Zinecard interfered with the effectiveness of cancer therapy by seeing if those who received Zinecard had more instances of original cancer relapse and new subsequent cancers compared to those who did not receive Zinecard.<br></li></ol> cancer;heart;pediatrics ALTE11C2 Rachel Lowery Betty H Melton Cancer Heart Health Pediatrics |
||||||||||
Key Adverse Events After Childhood CancerIRB Number: 2004-0159
Published: May 28, 2019
View Locations
Clinical Trial Locations:
|
20190528150602 |
This study is being conducted to identify key adverse events in survivors of childhood cancer, including cardiac dysfunction, ischemic stroke, avascular necrosis and subsequent malignant neoplasms. The study will also assist in identification of potential genetic risk factors that may be associated with the development of key events and allow for the exploration of genetic/environmental interactions.<br> cancer;pediatrics;cardiac ALTE03N1 Maggie Goad gmegason Cancer Genetics Heart Health Pediatrics Stroke/Traumatic Brain Injury |
||||||||||
LEAHRN (Late Effects After High-Risk Neuroblastoma) StudyIRB Number: 2017-0256
Published: May 28, 2019
View Locations
Clinical Trial Locations:
|
20190528151434 |
This study aims to evaluate the long term effects that modern therapy for high risk neuroblastoma has on long term survivors. <br> cancer;pediatrics ALTE15N2 Rachel Lowery Betty H. Melton Cancer Pediatrics |
||||||||||
Long-Term Outcomes after the Multisystem Inflammatory Syndrome in Children: MUSICIRB Number: 2020V0389
Published: October 22, 2021
View Locations
Clinical Trial Locations:
|
20211022104212 |
<div>This study will be an observational cohort study that will use routinely</div><div>collected clinical and cardiac (EKG, echocardiogram, CMR, exercise</div><div>testing) data to assess the association between MIS-C and cardiac</div><div>outcomes within the first year after hospital discharge.</div> heart;pediatrics;cardiology NCT04456439 Sandra Tyler dshakti Heart Health Pediatrics |
||||||||||
Long-Term Safety and Efficacy Outcomes Following Previously Administered Short-Term Treatment with SHP607 in Extremely Premature InfantsIRB Number: 2020V0107
Published: December 16, 2021
View Locations
Clinical Trial Locations:
|
20211216110945 |
To evaluate long-term efficacy outcomes following previously administered short-term exposure to SHP607, as
compared to a standard neonatal care group, as assessed by chronic respiratory morbidity (CRM) outcomes. pediatrics;neonatal medicine SHP607-203 Chelsea Giachelli abhatt Pediatrics |
||||||||||
MASTER: NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice)IRB Number: 2017-0245
Published: May 28, 2019
View Locations
Clinical Trial Locations:
|
20190528133239 |
The purpose of this study is to match targeted drugs with molecular changes that are identified in each participants tumor in children and adolescents with recurrent/refractory tumors.<br> cancer;pediatrics APEC1621 Maggie Goad mgoad Cancer Pediatrics |
||||||||||
Open-Label phase 1 study to assess the aaximum tolerated dose, Pharmacokinetics, and Safety of Ixazomib administered intravenously to pediatric patients Aged 0 to <18 years with relapsed or refractory aAcute Lymphoblastic Leukemia, with or without Extramedullary Disease, or welapsed or Refractory Lymphoblastic LymphomaIRB Number: 2019-0190
Published: August 26, 2019
View Locations
Clinical Trial Locations:
|
20190826151850 |
This study is to determine the maximum tolerated dose and/or recommended phase 2 dose of intravenous ixazomib when given in combination with reinducing chemotherapy in pediatric patients with relapsed or refractory ALL or LLy. To identify the safety and toxicity of intravenous ixazomib in combination with reinduction chemotherapy in those same patients. To characterize the pharmacokientics of IV ixazomib in combination with reinduction chemotherapy in those same patients. cancer;pediatrics;lymphoma C16051 Julie Hornaday Betty H. Melton Cancer Pediatrics |
||||||||||
Pharmacokinetics of Understudied Drugs Administered to Children per Standard of CareIRB Number: 2018-0115
Published: June 28, 2019
View Locations
Clinical Trial Locations:
|
20190628101637 |
This study will collect information about how various drugs affect children/young adults. The information collected will help develop a standard of care for prescribing drugs in this age group. pediatrics NICHD-2011-POP01 Lacy Malloch jmajure Pediatrics |
||||||||||
Premature Infants Receiving Milking or Delayed Cord Clamping: Randomized Controlled Multicenter Non-Inferiority Trial: PREMOD2IRB Number: 2019-0159
Published: November 25, 2019
View Locations
Clinical Trial Locations:
|
20191125100657 |
This study will compare the incidence of long-term neurodevelopmental outcomes at 24 months in premature infants receiving umbilical cord milking (UCM) to those receiving delayed cord clamping (DCC). pediatrics;women's health 1612901 Sandra Tyler skaram Pediatrics Women's Health |
||||||||||
Project: Every Child, A Registry, Eligibility, Screening, Biology, and Outcome StudyIRB Number: 2015-0278
Published: May 29, 2019
View Locations
Clinical Trial Locations:
|
20190529083623 |
This study is a mechanism of maintaining a Childhood Cancer Registry which will use clinical and biological data to determine eligibility for risk stratification on therapeutic studies. The study will also be used to develop a childhood cancer repository for current and future research by collecting biospecimens at the time of diagnosis, time of progression, time of recurrence and/or post-mortem from every child diagnosed with cancer at COG institutions. The study will also allow the use of registry data for permission to be contacted in the future to consider taking part in non-therapeutic and prevention research studies involving the child and/or their parents.<br> cancer;pediatrics APEC14B1 Theresa Hutson rlong Cancer Pediatrics |
||||||||||
Randomized, Controlled, Multi-Center Study to Assess the Efficacy, Safety, and Tolerability of Intravitreal Aflibercept Compared to Laser Photocoagulation in Patients with Retinopathy of PrematurityIRB Number: 2020-0010
Published: April 08, 2020
View Locations
Clinical Trial Locations:
|
20200408154611 |
This study will access the safety and effectiveness of aflibercept compared to laser in patients with Retinopathy of Prematurity (ROP). eyes/vision;pediatrics VGFTe-ROP-1920 Sandra Tyler dshakti Eyes/Vision Pediatrics |
||||||||||
Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of a Multi-Dose Regimen of Oral Varespladib-Methyl in Subjects Bitten by Venomous Snakes (BRAVO study – Broad-spectrum Rapid Antidote: Varespladib Oral for snakebite)IRB Number: 2021-1045
Published: January 24, 2022
View Locations
Clinical Trial Locations:
|
20220124232533 |
The purpose of this clinical research study is to learn more about the use of the study medicine, varespladib, for the treatment of snakebite. You or your child will receive a medication called Varespladib or placebo. Varespladib is an experimental treatment, meaning that it has not yet been approved by the Food and Drug Administration (FDA) for the treatment of snakebite. In this study, varespladib will be compared to a placebo. A placebo is a pill that looks exactly like the study medicine but does not contain any active ingredient, and has no therapeutic effect by itself. bravo;snakebite;varespladib-methyl (ly333013) OPX-PR-01 Simon Barinas dvearrier Emergency Medicine |
||||||||||
Renal Tumors Classification, Biology, and Banking StudyIRB Number: 2006-0069
Published: May 28, 2019
View Locations
Clinical Trial Locations:
|
20190528150621 |
A primary goal of the committee is to refine the current classification schema to better stratify patients into risk-appropriate treatment groups. Additional clinical and molecular factors are now known to be predictive of outcome. This study will therefore serve as the infrastructure for rapid and reliable acquisition of the results of proven prognostic markers (histopathology, disease stage, chromosome 1p and 16q allelic status (LOH) and response evaluation (diagnostic pulmonary imaging). <br> cancer;pediatrics ARENO3B2 Leslie Johnson bstronach Cancer Pediatrics |
||||||||||
Risk Stratified Randomized Phase III Testing of Blinatumomab in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL)IRB Number: 2015-0013
Published: May 28, 2019
View Locations
Clinical Trial Locations:
|
20190528152433 |
The study is being done to test whether the incorporation of blinatumomab into the treatment of patients with childhood B-Lymphoblastic Leukemia at first relapse will improve disease free survival. <br> pediatrics;cancer AALL1331 Maggie Goad Betty H Melton Cancer Pediatrics |
||||||||||
Role of Pseudomonas aeruginosa Serine Proteases and Staphylococcus aureus Toxins in Exacerbations of Cystic FibrosisIRB Number: 2016-0153
Published: June 27, 2019
View Locations
Clinical Trial Locations:
|
20190627132447 |
This is an observational study in cystic fibrosis patients looking at the influence of bacteria in causing infections in cystic fibrosis. Blood and sputum samples will be collected during a well visit and sick visits. Clinical data will be collected. lungs;pediatrics 2016-0153 Sandra Tyler jspurzem Digestive Conditions Lungs/Breathing |
||||||||||
Safety of Sildenafil in Premature Infants at Risk of Bronchopulmonary DysplasiaIRB Number: 2019-0108
Published: August 22, 2019
View Locations
Clinical Trial Locations:
|
20190822150258 |
This trial will study the safety and effectiveness of sildenafil in premature infants who are at risk of developing bronchopulmonary dysplasia (BPD). pediatrics;lungs NICHD-2015-SIL02 Chelsea Giachelli skaram Lungs/Breathing Pediatrics |
||||||||||
The Pediatric Spine RegistryIRB Number: 2019-0260
Published: November 25, 2019
View Locations
Clinical Trial Locations:
|
20191125105254 |
The Pediatric Spine Registry is operated by The Children's Spine Foundation. It will be comprised of clinical data that will be used retrospectively to study complex spine and chest wall disorders in children. The purpose of this database is to provide a multi-center patient registry allowing investigators to combine patient data of this very small patient population that will be used for future research for projects involving the study of complex spine and chest wall disorders in children. pediatrics;surgery;spine 2019-0260 Maris Hardee Hamdi Sukkarieh Pediatrics Surgery |
||||||||||
Vitamin D Supplementation in Children with Obesity-Related Asthma (VDORA1)IRB Number: 2019-0090
Published: June 28, 2019
View Locations
Clinical Trial Locations:
|
20190628094919 |
The purpose of the study is to learn more about Vitamin D levels in children who have asthma and are overweight or obese. pediatrics 228446 Lacy Malloch djosey Pediatrics Weight Management |